Outset Medical, Inc. (OM) vs Sera Prognostics, Inc. (SERA)

A side-by-side comparison of Outset Medical, Inc. and Sera Prognostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OM vs SERA

growth of $100 · dividends reinvested · last 5y
OM -99.4% (-63.9%/yr)SERA -83.2% (-30.0%/yr)SERA compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$1$17
OM SERA

OM vs SERA: by the numbers

  • •SERA is the larger company ($77M vs $76M market cap).
  • •Both run net losses; OM's is the smaller (-63.06% vs -47475.71% net margin).
  • •SERA grew revenue faster over the past five years (9.73% vs 8.28% CAGR).

Metrics side by side

Valuation

MetricOMSERA
P/S ratio0.651102.08
P/B ratio0.791.30

Profitability

MetricOMSERA
Gross margin41.76%-102.47%
Operating margin-56.06%-45066.67%
Net margin-63.06%-47475.71%
ROE-77.12%-55.97%
ROIC-33.27%-59.79%

Growth (annualized)

MetricOMSERA
Revenue CAGR (5Y)8.28%9.73%
Total return CAGR (5Y)-64.47%-28.91%

Frequently asked

Which has grown faster, OM or SERA?
Over the past five years, SERA grew revenue faster — OM at a 8.28% CAGR versus SERA at 9.73%.
How have OM and SERA total returns compared?
Over the past 5 years, OM delivered -64.47% and SERA delivered -28.91% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.